Is there any generic drug of Tazemetostat and its market situation analysis

Tazemetostat (Tazemetostat) is an oral small molecule EZH2 inhibitor, mainly used to treat relapsed or refractory peripheral T cell lymphoma and specific types of epithelial tumors. It exerts anti-tumor effects by inhibiting the methyl transfer activity of EZH2 and blocking the abnormal proliferation and differentiation of tumor cells. At present, tazerestat has been launched in China, providing a new treatment option for patients with related tumors. However, it has been on the market for a short time and the market coverage is still limited. If patients need to use it, they need to consult the local hospital pharmacy.

Regarding the situation of generic drugs, as of now, no official generic drug of tazerestat has been approved for marketing in China. Since the drug has just entered the market, the main supply is still dominated by original drugs. If patients want to reduce the cost of medication, they may consider purchasing generic drugs through formal overseas channels. In the foreign market, the original drug of tazetostat mainly includes the American version and the Japanese version. The price ranges from 10,000 to 20,000 yuan, which imposes a large financial burden, but the quality and ingredients are consistent with clinical trials.

In contrast, the prices of generic drugs provided in some overseas regions such as Laos are relatively affordable, with the price of each box being about more than 4,000 yuan. These generic drugs are basically the same as the original drugs in terms of drug ingredients and efficacy, providing patients with viable economic alternatives. When choosing overseas generic drugs, patients should ensure that the channels are formal to avoid purchasing counterfeit drugs or products of substandard quality. At the same time, patients should communicate with their attending doctor before use to formulate a rational medication plan.

Generally speaking, although tazerestat has been launched in China, it is mainly supplied with original drugs, and there are no generic drugs in China yet. Patients can obtain drugs through regular hospitals or overseas channels. In the future, with the promotion of drugs in the domestic market and the approval of related generic drugs, it is expected that prices may gradually decrease and access will become more convenient. Patients should consider the doctor's advice during use and arrange treatment plans reasonably to ensure the efficacy and safety of the drug.

Reference materials:https://www.drugs.com/